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McCOY CELL LINE AS A POSSIBLE MODEL CONTAINING CD4+ RECEPTORS
FOR THE STUDY OF HIV-1 REPLICATION
Yeda L. NOGUEIRA(1), Carmen A. Freitas OLIVEIRA(1), Antonio Gomes P. FERREIRA(2), Paulo M. NAKAMURA( 1) & Antonio Carlos MAGNANELLI(3)
SUMMARY
Several studies have recently shown the use of recombinant rabies virus as potential vector-viral vaccine for HIV-1. The sequence
homology between gp 120 and rabies virus glycoprotein has been reported. The McCoy cell line has therefore been used to show
CD4+ or CD4+ like receptors.
Samples of HIV-1 were isolated, when plasma of HIV-1 positive patients was inoculated in the McCoy cell line. The virus
infection was then studied during successive virus passages. The proteins released in the extra cellular medium were checked for
protein activity, by exposure to SDS Electrophoresis and blotting to nitro-cellulose filter, then reacting with sera of HIV positive and
negative patients.
Successive passages were performed, and showed viral replication, membrane permeabilization, the syncytium formation, and
the cellular lysis (cytopathic effect).
Flow cytometry analysis shows clear evidence that CD4+ receptors are present in this cell line, which enhances the likelihood of
easy isolation and replication of HIV.
The results observed allow the use of this cell line as a possible model for isolating HIV, as well as for carrying out studies of the
dynamics of viral infection in several situations, including exposure to drugs in pharmacological studies, and possibly studies and
analyses of the immune response in vaccine therapies.
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INTRODUCTION
Many studies have demonstrated details of molecular interaction
between acquired immunodeficiency virus (AIDS/HIV) and the biology
of host cells14.
For the virus to enter a target cell, the viral envelope must fuse with
the cell membrane. This fusion is mediated by the glycoprotein48 of the
viral envelope10,21,54.
Selective pressure has imposed the need for specialization of viral
proteins to permit the occurrence of interaction of the genetic material
of the virus with the host cell54.
HIV, in particular, uses the glycoprotein of 120 kDa molecular weight
(gp120) of the viral envelope to adhere to the host cell. This adhesion
depends on a specific receptor located on the cell membrane denoted
CD4, which is also a glycoprotein of 55 kDa molecular weight. The
interaction between the two molecules is of a high-affinity type,
permitting the gp120 molecule and the surface receptor to perform
endocytosis of the viral particle11,21,54. This mechanism has been
preliminarily reported for target cells, i.e., T/CD4+ lymphocytes16,38,51.
However, other cells also express the CD4 receptor, i.e., monocytes,
dendritic cells, as well as glial cells of the central nervous system, in
addition to macrophages, which are the main target cell (in vitro) for
simian immunodeficiency virus (SIV)54.
The main function of CD4 binding is to induce conformational
changes in gp120 that contribute to the formation or expression of binding
sites for cytochemical receptors8,12,15,21,38. Some HIV-1 and HIV-2 viruses
isolated from culture cells in the laboratory, as well as many primary
virus isolates - SIV - have proved not to depend on CD4 to enter the cell,
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but to be able to bind to chemokine receptors of the alpha and beta type
(X4 and R5), act as co-receptors for HIV together with CD4, and carry
out important functions in the isolation of some retrovirus types4,15.
More recent studies have demonstrated that the CCR5 and CXCR4
co-receptors are related to membrane fusion when the virus enters the
cell. The probable sequence of events is as follows: HIV first enters the
cell, with the viral envelope binding to CD4 through gp120/41, a
conformational change occurs in gp120, which is altered, thus binding
to the co-receptors, and finally coalescence of the viral envelope and
cell membranes occurs. Infected cells continue to express the gp120/41
receptor on the cell surface during infection both before the incorporation
of newly formed virions (virus particles) by the cell membrane and after
virion exocytosis (budding) into the extracellular medium44,54.
Other studies have demonstrated the possibility that HIV pseudotypes
may enter the cells through this same receptor43,44 or closely similar
receptors. These pseudotypes may be viruses like vesicular stomatitis
virus (VSV), which is a rhabdovirus, that may be modified and induced
to express proteins of the HIV-1 virus30,42 . Anti-HIV vaccines have been
based on these hybrid pseudotypes mimicking HIV, and have been
developed with the VSV42.The physicochemical and biological properties
of these pseudoviruses have served as the basis for the production of
anti-HIV vaccines44.
Previous studies have also reported the homology of a protein
sequence of HIV gp120 with the neurotoxic loop region of the rabies
virus and also of the neurotoxins of snake venom23,32,47. The McCoy cell
line was shown to be efficient for the replication and isolation of rabies
virus33,34.
The present investigation was based on the cited studies in order to
evaluate HIV replication in McCoy cells and to test the hypothesis that
McCoy cells have CD4 type or CD4-like receptors on the cell membrane.
MATERIAL AND METHODS
Cell culture: The McCoy lineage cells used were obtained from the
Cell Culture Section of the Adolfo Lutz Institute, which is a hybrid lineage
with markers from human cells and mouse cells. This cell is registered
in the American Type Culture Collection under number CRL 16962.
Identification of HIV-1: The plasma of a patient infected with HIV-
1 admitted to the Children’s Hospital (São Paulo, Brazil) in 1994 was
provided by the plasma bank, Section of Immunology, Adolfo Lutz
Institute. The plasma (1 mL) was inoculated into cell culture plates 6 cm
in diameter containing 3 ml Eagle medium supplemented with 5% fetal
calf serum and a monolayer of confluent McCoy cells. Changes in cell
morphology were observed until the occurrence of a total or partial
cytopathic effect depending on viral titer. A one-mL sample was
withdrawn after every passage, and once again inoculated into another
bottle containing a monolayer of freshly split cells. Each successive
passage of the inoculate remained until there was cellular lysis of the
majority of cells, approximately 80% of cells. Duration ranged from 10
days in the first passages to 5 days in the last passages, when the titer
was higher. Up to 11 passages were carried out.
Viral replication kinetics was performed and observed through
changes in cell morphology; 0.2 mL of the sample of HIV-1 isolate in
McCoy cells (5th passage) was reinoculated in a monolayer of cells for
30 minutes for adsorption of the virus in the cells and then a further 2
mL of Eagle medium supplemented with 2% fetal calf serum was added.
Five more plates containing uninfected McCoy cells served as controls.
All plates were observed for morphology for 120 hours; each pair of
plates contained coverslips where the cells grew. Every 24 hours the
coverslips (containing both infected and control cells) were fixed using
an aqueous solution of alcohol and acetic acid and processed for
histological staining by Hematoxilin-Eosin (HE).
Immunofluorescence: Indirect immunofluorescence (IFI) was used
to observe the infected cells. Positive and negative sera for anti-HIV-1
antibodies were tested with the set of reagents of the IFI-HIV-1 kit
produced at Biomanguinhos. IFI was performed by standard procedures:
1) Coverslips placed on the culture plates contained HIV-1-infected cells;
120 hours after virus inoculation, the coverslips were washed with
buffered saline solution and fixed in acetone at -20 oC for 10 minutes. 2)
After drying, the coverslips were analyzed for reactivity of sera positive
and negative for anti-HIV antibodies by immunologic reaction for 30
minutes in a moist chamber. 3) After incubation, a series of three washes
of five minutes each in buffered physiological saline was performed. 4)
The next step consisted of the addition of fluorescein-labeled human
serum (conjugate) over the first reaction performed on the coverslip,
also for a period of 30 minutes followed by three washes as described in
item 3. Finally, the coverslips were dried and mounted on a larger
coverslip for reading under the immunofluorescence microscope (IM-
35, Zeiss).
Viral load: The last three passages (9th, 10th and 11th) were tested
for the presence of virus by assessing the increase in viral load using
Nasba-Organon equipment. Two-mL samples of each of the passages
mentioned above were subjected to analysis, along with other routine
blood samples tested at Retrovirus Laboratory of the Instituto Adolfo
Lutz. Viral load values were below the detection threshold for which the
equipment was configured, but it was possible to observe an increase
between the 10th and 11th passages from 20 to 79 copies.
Isolation of HIV-1: HIV-1-infected McCoy cells cultured for
approximately 10 days were centrifuged at 400 x g/min. The supernatant
was removed, distributed into Sorwall type centrifuge tubes and
centrifuged at 17,000 rpm for three hours at 4 oC . The pellet was
resuspended in a total volume of 1 ml Tris-NaCl-EDTA (TNE) buffer
and stored overnight at 4 oC.
The virus was purified on a chromatography column packed with
10 ml Sepharose 4B at room temperature. The eluate came immediately
after void volume, approximately between 2.0 to 2.5 ml. The eluate was
then centrifuged again in a microcentrifuge at 14,000 rpm for 1:30 hours.
After removal of the supernatant, the pellet was resuspended in 150 µl
buffer + 0.5% Triton X-100 in CMF-PBS for separation of HIV-1 viral
protein by SDS-PAGE22.
Western-blotting: After viral protein separation by SDS-PAGE, the
separated proteins were transferred to a nitrocellulose strip and submitted
to enzymatic reaction with serum samples from HIV-positive and HIV-
negative (control) patients previously tested with a diagnostic kit.
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Evaluation of CD4 type receptors in McCoy cells by flow cytometry:
Qualitative and quantitative measurements of human CD4 surface
expression on McCoy cells were determined by flow cytometry using
acquisition and analysis. Surface staining was performed on 50 µL of
105 cells/mL with satured amounts of mouse anti-human CD4 fluorescein
isothiocyanate (FITC) (DAKOPATTS, code F 766) and mouse anti-
human CD3/CD4/CD8 conjugated monoclonal antibodies (TRITEST,
Becton Dickinson Immunocytometry Systems - BDICS). The TRITEST
reagent, routinely used for CD4 phenotype was used as a second, distinct
antibody from a different source for positive staining control.
Fluorescence was analyzed using a FACSort flow cytometer (BDICS)
equipped with an argon ion 488 nm laser source. FICT emission was
collected with a filter at 530 nm wavelength (FL1). Cell size and granulosity
were evaluated morphometrically by analysis of dispersal of transmitted
light and of dispersal of light at 90o, respectively collected with FSC and
SSC photomultipliers. The collecting filters were calibrated electronically
using Calibrite beads (BDICS) and the resources of the system. Acquisition
parameters were standardized by manual fine adjustments.
The morphometric, immunophenotypic and isotypic characteristics
of the labeled cells were studied by analysis of the acquired data with
the CELL-QUEST software (BDICS).
RESULTS
Figure 1A shows infected McCoy cells with altered morphology
compared to control cells (Fig. 1B). The immunofluorescence illustrated
in Figure 1C demonstrates that the morphology of infected cell + positive
serum present a more fluid morphology of the cytoplasm and the contours
of the cell membrane (greenish color). The control cells (not infected) +
positive serum show an intact membrane of reddish color (Fig. 1D).
Figure 2 shows the viral proteins present in the infected cells that
were visualized on the nitrocellulose strip by Western blotting. The
serologic reaction of band precipitation was performed with positive
patient serum (Fig. 2B), and the protein produced on a larger scale was
p24, while the glycoproteins gp160, gp120 and gp41 as were produced
on a smaller scale. The p31, p55 and 51, p18 and p15 proteins were
Fig. 1 - Shows photomicrographs of infected (A) and control (B) cells stained with hematoxylin-eosin obtained 120 hours after HIV-1 inoculation. Both cells showed a predominance of
eosinophilia (bluish color). C and D cells are also infected and control cells visualized by immunofluorescence. In these photographs, the observation was made at higher magnification and the
infected cells (C) show a greenish staining typical of positive reactions, whereas the control cells (D) show reddish staining.
Fig. 2 - Shows the results of Western-blotting: the proteins obtained from infected McCoy
cells after electrophoretic separation (SDS-PAGE) and transfer to cellulose strips were
submitted to immunoprecipitation with serum from seropositive and seronegative patients
with respective densitometries obtained with the Labscan equipment (Pharmacia-Biotech).
(A) Prestained molecular weight standards from Biorad, # 85611- MW 7 -132 kDA-1)132
kDa; 2)78 kDa; 3)45.7 kDa; 4)32.5 kDa; 5)18.4 kDa and 6)7.6 kDa.; (B) serologic reaction
of the nitrocellulose strip with the infected McCoy cell + positive serum 1) gp160; 2) gp120;
3) p64; 4) p55; 5) p53; 6) gp41; 7) p31; 8) p24; 9) p18; 10) p15 and (C) the same reaction but
with a negative serum.
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present, and all proteins present were encoded by the major genes
corresponding to the pol-env-gag loci of HIV-17.
In the reaction with negative serum, no proteins with the same
molecular weight as the proteins cited above were identified (Fig. 2C).
The result of densitometry of the bands precipitated on the
nitrocellulose strip, which characterizes the molecular weights of each
band and the quantity of their virus replication production.
Figure 3 shows the result of the hypothesis raised. McCoy cells have
CD4 receptors as proven by flow cytometry, which was used to measure
the quantity of cells bound to the fluorescein-labeled CD4 antibody.
These results were confirmed by the statistical significance of the non-
parametric Kolgomorov-Smirnov test45 (Table 1).
Table 2 shows the quantity of cells bound to the fluorescein-labeled
CD4 antibody versus the inespecific Fc fraction isotypic mouse IgG1
bound to the cells, the results were also confirmed by the statistical
significance of the non-parametric Kolgomorov-Smirnov test45.
DISCUSSION
The change in morphology was shown by an increase in area and in
granulosity both in the cytoplasm and inside the nucleus, which was not
observed in non-infected control cells1,6. According to these authors and
others31, the increase in permeability may be due to the concentration of
intracellular Ca++.
This result shows why McCoy cells can isolate HIV-1 from plasma of
seropositive patients and can also replicate the virus. This was verified by
Table 1
Cells parameters, # events, mean, median and standard deviation
Parameters Events Mean ( C.I.) Median (C.I.) sd
1) Control Cell without Ab 19033 3.65 (3.64 - 3.68) 3.31 (3.27 - 3.35) 1.86
2) Cells * + Ab CD3/4/8 13247 6.06 (6.02 - 6.08) 5.68 (5.67 - 5.69) 2.38
3) Cells * + MAb CD4 8944 39.16 (39.08 - 39.240) 36.85 (36.77 - 36.93) 11.64
(C.I.) Confidential Interval; * Cells not infected.
The fluorescence intensities in FL1 were compared using as parameters the mean of the values attributed to light intensity and tested in each channel, the anti-
CD4 antibody was found to label more receptors (mean = 39.16) than the anti-CD3/CD4/CD8 antibody (mean = 6.06). The light emission captured by the two cell
populations presented a distribution close to normal, although with different mean and median values. The non- parametric Kolgomorov-Smirnov test was used
for statistical analysis and the differences between control cells + BBS and cells + anti-CD4 were significant at p ‹ 0.001, α = 0.05%.
Table 2
Cells parameters, # events, mean, median and standard deviation
Parameters Events Mean ( C.I.) Median (C.I.) sd
1) Cells* + CD4 Ab 2770 21.95 (21.73 – 22.17) 20.54 (20.32 – 20.76) 5.92
2) Cells* + isotypic Ab 6367 7.79 (7.69 – 7.79) 7.77 (7.67 – 7.87) 3.89
(C.I.) Confidential Interval; * Cells not infected.
The fluorescence intensities in FL1 were compared using as parameters the mean of the values attributed to light intensity and tested in each channel, the anti-
CD4 antibody was found to label more receptors (mean = 23.95) than the anti-mouse IgG1 (isotypic antibody) (mean = 3.69). The light emission captured by the
two cell populations presented a distribution close to normal, although with different mean and median values. The non- parametric Kolgomorov-Smirnov test was
used for statistical analysis and the differences between McCoy cells + isotypic antibody and McCoy cells + anti-CD4 were significant at p ‹ 0.001, α = 0.05%.
Fig. 3 - Shows the results of flow cytometry carried out to determine the presence of CD4
receptors in cells of the McCoy lineage. Morphometric analysis of McCoy cells using a
bidirectional histogram (dot plot) of FSC and SSC revealed a homogeneous population of
relatively small size and of moderate granulosity (Figures not shown). The expression of
fluorescence in FL1 was evaluated. The presence of CD4 expression was evaluated in Figure
3: (A) control cells (not infected) + BSS without antibody versus uninfected cells, labeling
with anti-CD3/CD4/CD8(¾/- -); (B) shows control cells + BBS versus uninfected cells labeling
with the monoclonal antibody anti-CD4(¾ /- -).
analyzing samples of passages of infected cell fluid in terms of viral load.
In the 11th passage it was possible to measure 79 copies in 2 ml, which is
equivalent to approximately 40 copies/ml, a much higher value than that
reported later5,35, the authors estimated less than 20 copies/ml to be the
capacity of a cell of the organism of HIV-1-infected patients during the
phase of clinical manifestation of the disease. Thus, data observed in the
present study show the ability of McCoy cells to produce at least twice the
amount of virus (viral load methodology), which makes McCoy cells a
possible model for in vitro study of the dynamics of HIV-1 infection.
This cell also presents human CD4 receptors, which probably
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increases its capacity to replicate HIV-1. The McCoy cells used in this
study are hybrid cells containing chromosome markers both for human
cells and mouse cells (ATCC)2,12,36.
However, in order to confirm that results obtained with anti-CD4
marking were specific for the receptor and not an unspecific reaction of
the Fc fraction of the IgG molecule, an experiment was also performed
using isotypical mouse antibodies of the same type as monoclonal human
anti-CD4 antibodies. The results shown in Table 2 reveal that there is
marking for isotypical antibodies, but there is much more marking for
anti-CD4-receptor antibodies.
However, this cell may well express part of its murine genome, since
murine cells present a reduced capacity to replicate HIV-1. Cells of mouse
lineages such as Rat2 and Nb2 have shown a capacity to produce the
virus from 10 to 60 times less than human cells20.
Some studies20,28,40 have shown murine cell capacity for HIV-1
infection, in other words, the capacity for the virus to penetrate the cell,
the integration and expression of products in the early and late stages,
and the viral egress at different levels depending on the type of cell and
its animal origin.
The advent of transgenic cells has enabled expression of human CD4,
CCR5 co-receptors and T1 cycline molecules in murine cells, which
have successfully replicated HIV-1 in vitro28,37. However, transgenic cells
have shown a certain incapacity to liberate HIV37. This may explain why
it has only been possible to observe HIV-1 proteins replicated in McCoy
cells after treatment with lysis buffer containing EDTA to promote cellular
lysis; the best results were obtained when this solution was immersed in
an ultrasound bath. These results were observed in tests with elution of
infected cells Fast Protein Liquid Chromatograph (FPLC) equipment to
verify the molecular weight of the proteins extracted from the cells. This
treatment has enabled observation of peaks of expression from gp160 to
gp120 greater than the peaks observed when the cells were not subjected
to this (data not demonstrated).
It remains to be determined whether the low glycoprotein (gp160
and gp120) concentration is due to the extraction method or if it is related
to the concentration of CD4 receptors existing in McCoy cells that might
sequester the glycoproteins (gp160) formed de novo, being reintegrated
with the cell membrane and forming a conformational reaction through
the gp120/41 complex (non-covalent association) expressed on the cell
membrane9,48. This complex may join other CD4 receptors of nearby
cells, forming syncytia25,26,46. This is a high-affinity interaction, so that
the method used in the process may impair extraction since it would not
be efficient in loosening the glycoproteins and another part would be
lost in the cell debris. A definitive statement cannot be made at present,
but this analysis will be the subject of a future study.
In the present study no comment on the actions of the CCR5 and
CXCR4 co-receptors (chemokines)3 or on the action of fusins in the
mechanism of syncytium formation51,53,54 was presented since no specific
experiment to evaluate the presence of these receptors in McCoy cells
was performed.
In conclusion, the present results permitted visualization of some
important biological phenomena such as HIV-1 replication, the formation
of giant cells, membrane permeabilization, and the presence of receptor
CD4, which occur in McCoy cells infected with HIV-1. These
observations could represent a good model to study the dynamics of
viral replication and drug action or to induce virus modification
(recombinant virus, genetic therapy) and observe the action mechanisms
and cell function alterations in vitro, possibly in addition to vaccine
therapy immune response trials and analyses.
RESUMO
Células de linhagem McCoy como um possível modelo contendo
receptores CD4+ para estudos da replicação do HIV
Recentes estudos demonstraram o uso do vírus raiva como
modelo vetor para produzir vacinas expressando as glicoproteínas do
vírus HIV-1. A homologia na seqüência entre gp120 do vírus HIV-1 e a
glicoproteína G do vírus rábico já foi previamente relatada. Devido a
estes fatos a linhagem de célula McCoy utilizada com sucesso para a
replicação do vírus rábico foi utilizada para demonstrar a replicação do
HIV-1.
Amostra de HIV-1 foi isolada de plasma de um paciente soro positivo
e inoculada em células de linhagem McCoy e então a infecção viral foi
estudada em passagens sucessivas do vírus nesta célula. As proteínas
liberadas no meio extra celular foram analisadas quanto a atividade
biológica pela técnica de eletroforese em gel de poliacrilamida e
imunotransferência em membrana de nitro-celulose reagindo com soros
positivos para HIV-1 e soros de pacientes negativos.
As passagens sucessivas do HIV-1 em células demonstraram a
replicação viral, o aumento da permeabilidade da membrana
citoplasmática, a formação de sinsício e lise celular.
Análises com citometria de fluxo mostraram com clara evidência a
presença de receptores CD4+ o que possivelmente deve ser a causa que
possibilita a facilidade do isolamento e replicação do vírus HIV-1 nesta
célula.
Concluindo os resultados observados permitem utilizar esta linhagem
celular como um possível modelo para isolamentos de HIV, bem como
realizar estudos da dinâmica de infecção viral em diversas situações
inclusive de exposição a drogas em estudos farmacológicos, e talvez
estudos e análises da resposta imune em terapias vacinais.
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